@article {1517179, title = {Uveitis Therapy: The Corticosteroid Options}, journal = {Drugs}, volume = {80}, number = {8}, year = {2020}, month = {2020 Jun}, pages = {765-773}, abstract = {Uveitis is characterized by intraocular inflammation involving the uveal tract; its etiologies generally fall into two broad categories: autoimmune/inflammatory or infectious. Corticosteroids \ are a powerful and important class of medications ubiquitous in the treatment of uveitis. They may be given systemically or locally, in the form of topical drops, periocular injection, intravitreal suspension, or intravitreal implant. This review describes each of the currently available corticosteroid treatment options for uveitis, including favorable and unfavorable characteristics of each as well as applicable clinical trials. The main advantage of corticosteroids as a whole is their ability to quickly and effectively control inflammation early on in the course of uveitis. However, they can have serious side effects, whether localized to the eye (such as cataract and elevated intraocular pressure) or systemic (such as osteonecrosis and adrenal insufficiency) and in the majority of cases of uveitis are not an appropriate option for long-term therapy.}, issn = {1179-1950}, doi = {10.1007/s40265-020-01314-y}, author = {Valdes, Lianna M and Sobrin, Lucia} }